8FIV

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor Jun10541R

8FIV の概要

• エントリーDOI: 10.2210/pdb8fiv/pdb
• 分子名称: 3C-like proteinase nsp5, (3Z)-N-([1,1'-biphenyl]-4-yl)-3-imino-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]propanamide (2 entities in total)
• 機能のキーワード: sars-cov-2 mpro, main protease, viral protein, hydrolase-inhibitor complex, hydrolase/inhibitor
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 34302.12

構造登録者

Sacco, M.,Wang, J.,Chen, Y. (登録日: 2022-12-16, 公開日: 2023-08-09)

• 主引用文献: Tan, B.,Sacco, M.,Tan, H.,Li, K.,Joyce, R.,Zhang, X.,Chen, Y.,Wang, J.; Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors.; Eur.J.Med.Chem., 259:115667-115667, 2023; PubMed: 37482021; DOI: 10.1016/j.ejmech.2023.115667

実験手法

X-RAY DIFFRACTION (2.51 Å)